A novel curcumin derivative, C210, activates the Epstein–Barr virus (EBV) lytic cycle without producing infectious virions by disrupting HSP90. This discovery opens avenues for safer EBV-positive cancer therapies.
Presidential debate moderators should ask about mental health policy
As the mom of three young adults, I am worried about their economic future — their ability to get jobs and afford homes. But I